Life Technologies Corporation - Medical Equipment - Deals and Alliances Profile

Date: October 7, 2015
Pages: 87
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: LE9FD357130EN
Leaflet:

Download PDF Leaflet

Life Technologies Corporation - Medical Equipment - Deals and Alliances Profile
Summary

Life Technologies Corporation (Life Technologies) is a biotechnology company, which offers a wide range of products such as instruments, systems and reagents. It offers its products through three divisions, namely, life sciences, applied sciences and clinical diagnostics. The company’s products are used in wide range of applications such as cell analysis, cell culture and transfection, cell engineering and genome editing, cloning, DNA and RNA purification, gene expression analysis and geno typing, PCR, protein expression and analysis, real time PCR, RNAi, sequencing, bioproduction, animal health, food safety, human identification, molecular diagnostics, diagnostic development, clinical and translational research and public health. The company also provides clinical laboratory services. It operates in more than 180 countries and has about 5,000 patents and exclusive licenses. Life Technologies is headquartered in California, the US.

Life Technologies Corporation - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Life Technologies Corporation, Medical Equipment, Deals By Year, 2009 to YTD 2015
Life Technologies Corporation, Medical Equipment Deals By Type, 2009 to YTD 2015
Life Technologies Corporation, Medical Equipment, Deals By Region, 2009 to YTD 2015
Life Technologies Corporation, Medical Equipment, Deals By Market, 2009 to YTD 2015
Life Technologies Corporation, Medical Equipment, Deals Summary, 2009 to YTD 2015
Life Technologies Corporation, Medical Equipment, Deal Details
Asset Purchase
Invitrogen BioServices India Completes Acquisition Of Applied Biosystems Agency Business Of Labindia
Life Technologies Acquires Arcturus LCM Business From MDS
Partnerships
Life Technologies Enters Into Licensing Agreement With Quest Diagnostics For Development Of Molecular Tests
Medicyte Enters Into Licensing Agreement With Life Technologies For Next Generation Upcyte Cells
Life Technologies Enters Into Licensing And Research Agreement With Harvard For Stem Cell Assay
Vela Diagnostics Enters Into Licensing Agreement With Life Technologies
Roche Enters Into Licensing Agreement With Life Technologies For PCR Technology
Eurogentec Enters Into Licensing Agreement With Applied Biosystems
Life Technologies Enters Into Licensing Agreement With Zymera
Life Technologies Extends R&D Agreement With Dnavec For CytoTune-iPS 2.0 Sendai Reprogramming Kit
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics
Life Technologies Enters Into Agreement With RainTree For Molecular Tumor Testing
Rheonix Enters Into Co-Development Agreement With Life Technologies For Molecular Testing Platform
Life Technologies Enters Into Agreement With Merck Serono To Develop And Commercialize Companion Diagnostics
Life Tech Enters Into Distribution Agreement With LGC Forensics For ParaDNA
BioDesign Institute Enters Into Co-Development Agreement With Life Technologies
Boston Children's Hospital Enters Into Joint Venture With Life Technologies To Form Claritas Genomics
CollabRx Enters Into Co-Development Agreement With Life Technologies
Ingenuity Systems Enters Into Co-Development Agreement With Life Technologies For Diagnostic Solutions
Life Technologies Enters Into Co-Marketing Agreement With Pathogenica
Life Technologies Enters Into Agreement With Bristol-Myers Squibb For Companion Diagnostics Development
Life Technologies and Southern African Treatment and Resistance Network Partner In Sequencing-Based Surveillance of Drug Resistance
Gen-Probe Enters Into Co-Marketing Agreement With Life Technologies
Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies
Life Technologies Enters Into Joint Venture Agreement With DaAn Gene
Life Technologies Enters Into Co-Development Agreement With GlaxoSmithKline Biologicals
Sage Science Enters Into Co-Marketing Agreement With Life Technologies
Life Technologies Enters Into Co-Marketing Agreement With Quidel
Life Technologies, Oxford Biomedical Research Centre, AstraZeneca And ORD Enter Into Co-Development Agreement
Luminex Enters Into Distribution Agreement With Life Technologies
Rapid Micro Biosystems Enters Into Co-Marketing Agreement With Life Technologies
Life Technologies Enters Into Co-Marketing Agreement With PathoFinder
Life Technologies Enters Into An Agreement With Gen-Probe
Life Technologies Enters Into Co-Marketing Agreement With TrimGen
Asuragen Signs An Agreement With Life Technologies
Eppendorf Enters into Licensing Agreement with Life Tech and Alpha Labs
Life Technologies Enters Into Licensing Agreement With Novartis
Life Technologies Enters Into Licensing Agreement With Novici Biotech
Debt Offering
Life Technologies Completes Public Offering Of Senior Notes Due 2016 For US$400 Million
Life Technologies Completes Public Offering Of Senior Notes Due 2021 For US$400 Million
Life Technologies Completes Public Offering Of 3.38% Senior Notes For US$250 Million
Life Technologies Completes Public Offering Of 4.4% Senior Notes For US$500 Million
Life Technologies Completes Public Offering Of 6% Senior Notes For US$750 Million
Acquisition
Thermo Fisher Scientific Completes Acquisition Of Life Technologies For US$13.6 Billion
Life Technologies Acquires KDR Biotech, Distributor Of Reagents
Life Technologies Acquires Advanced Microscopy, Maker Of Microscopes
Life Technologies Acquires Pinpoint Genomics, Molecular Diagnostics Company
Life Technologies Acquires Navigenics
Life Technologies Acquires Immuno-Magnetic Diagnostics Company, Matrix MicroScience
Kernel Management Partners Sells Its 37% Stake In Stokes Bio To Life Technologies
Danaher Acquires Remaining 50% Interest In AB SCIEX From Life Technologies
Life Technologies Completes Acquisition Of AcroMetrix
Life Technologies Corporation - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Legal and Regulatory
Jul 29, 2014: Enzo Biochem Announces August 18, 2014 as Date of Markman Hearing in Patent Infringement Lawsuit Against Leading Life Sciences Companies
Product News
Apr 28, 2014: Tepnel Pharma Services Achieves Certification for Ion Torrent PGM Sequencing
Other Significant Developments
Jan 09, 2014: Life Technologies to Provide Ion Torrent Sequencing Platform to Quest Diagnostics for Development of New Molecular Tests
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Life Technologies Corporation, Medical Equipment, Key Facts
Life Technologies Corporation, Medical Equipment, Deals Summary, 2009 to YTD 2015
Life Technologies Corporation, Medical Equipment, Deals By Year, 2009 to YTD 2015
Life Technologies Corporation, Medical Equipment Deals By Type, 2009 to YTD 2015
Life Technologies Corporation, Medical Equipment, Deals By Region, 2009 to YTD 2015
Life Technologies Corporation, Deals By Market, 2009 to YTD 2015
Life Technologies Corporation, Medical Equipment, Deals Summary, 2009 to YTD 2015
Invitrogen BioServices India Completes Acquisition Of Applied Biosystems Agency Business Of Labindia
Life Technologies Acquires Arcturus LCM Business From MDS
Life Technologies Enters Into Licensing Agreement With Quest Diagnostics For Development Of Molecular Tests
Medicyte Enters Into Licensing Agreement With Life Technologies For Next Generation Upcyte Cells
Life Technologies Enters Into Licensing And Research Agreement With Harvard For Stem Cell Assay
Vela Diagnostics Enters Into Licensing Agreement With Life Technologies
Roche Enters Into Licensing Agreement With Life Technologies For PCR Technology
Eurogentec Enters Into Licensing Agreement With Applied Biosystems
Life Technologies Enters Into Licensing Agreement With Zymera
Life Technologies Extends R&D Agreement With Dnavec For CytoTune-iPS 2.0 Sendai Reprogramming Kit
Life Technologies Enters Into Distribution Agreement With Advanced Cell Diagnostics
Life Technologies Enters Into Agreement With RainTree For Molecular Tumor Testing
Rheonix Enters Into Co-Development Agreement With Life Technologies For Molecular Testing Platform
Life Technologies Enters Into Agreement With Merck Serono To Develop And Commercialize Companion Diagnostics
Life Tech Enters Into Distribution Agreement With LGC Forensics For ParaDNA
BioDesign Institute Enters Into Co-Development Agreement With Life Technologies
Boston Children's Hospital Enters Into Joint Venture With Life Technologies To Form Claritas Genomics
CollabRx Enters Into Co-Development Agreement With Life Technologies
Ingenuity Systems Enters Into Co-Development Agreement With Life Technologies For Diagnostic Solutions
Life Technologies Enters Into Co-Marketing Agreement With Pathogenica
Life Technologies Enters Into Agreement With Bristol-Myers Squibb For Companion Diagnostics Development
Life Technologies and Southern African Treatment and Resistance Network Partner In Sequencing-Based Surveillance of Drug Resistance
Gen-Probe Enters Into Co-Marketing Agreement With Life Technologies
Exosome Diagnostics Enters Into Technology Integration Agreement With Life Technologies
Life Technologies Enters Into Joint Venture Agreement With DaAn Gene
Life Technologies Enters Into Co-Development Agreement With GlaxoSmithKline Biologicals
Sage Science Enters Into Co-Marketing Agreement With Life Technologies
Life Technologies Enters Into Co-Marketing Agreement With Quidel
Life Technologies, Oxford Biomedical Research Centre, AstraZeneca And ORD Enter Into Co-Development Agreement
Luminex Enters Into Distribution Agreement With Life Technologies
Rapid Micro Biosystems Enters Into Co-Marketing Agreement With Life Technologies
Life Technologies Enters Into Co-Marketing Agreement With PathoFinder
Life Technologies Enters Into An Agreement With Gen-Probe
Life Technologies Enters Into Co-Marketing Agreement With TrimGen
Asuragen Signs An Agreement With Life Technologies
Eppendorf Enters into Licensing Agreement with Life Tech and Alpha Labs
Life Technologies Enters Into Licensing Agreement With Novartis
Life Technologies Enters Into Licensing Agreement With Novici Biotech
Life Technologies Completes Public Offering Of Senior Notes Due 2016 For US$400 Million
Life Technologies Completes Public Offering Of Senior Notes Due 2021 For US$400 Million
Life Technologies Completes Public Offering Of 3.38% Senior Notes For US$250 Million
Life Technologies Completes Public Offering Of 4.4% Senior Notes For US$500 Million
Life Technologies Completes Public Offering Of 6% Senior Notes For US$750 Million
Thermo Fisher Scientific Completes Acquisition Of Life Technologies For US$13.6 Billion
Life Technologies Acquires KDR Biotech, Distributor Of Reagents
Life Technologies Acquires Advanced Microscopy, Maker Of Microscopes
Life Technologies Acquires Pinpoint Genomics, Molecular Diagnostics Company
Life Technologies Acquires Navigenics
Life Technologies Acquires Immuno-Magnetic Diagnostics Company, Matrix MicroScience
Kernel Management Partners Sells Its 37% Stake In Stokes Bio To Life Technologies
Danaher Acquires Remaining 50% Interest In AB SCIEX From Life Technologies
Life Technologies Completes Acquisition Of AcroMetrix
Life Technologies Corporation, Key Competitors
Life Technologies Corporation, Key Employees
Life Technologies Corporation, Subsidiaries

LIST OF FIGURES

Life Technologies Corporation, Medical Equipment, Deals by Type, 2009 to YTD 2015
Life Technologies Corporation, Medical Equipment, Deals By Year, 2009 to YTD 2015
Life Technologies Corporation, Medical Equipment, Deals By Region, 2009 to YTD 2015
Life Technologies Corporation, Medical Equipment, Deals By Market, 2009 to YTD 2015
Life Technologies Corporation, Medical Equipment, Deals By Year, 2009 to YTD 2015
Life Technologies Corporation, Medical Equipment, Deals by Type, 2009 to YTD 2015
Life Technologies Corporation, Medical Equipment, Deals By Region, 2009 to YTD 2015
Life Technologies Corporation, Medical Equipment, Deals by Market, 2009 to YTD 2015
Skip to top


Ask Your Question

Life Technologies Corporation - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: